4073 Results

People

  1. Hudis
    Hudis
  2. Giralt
    Giralt
  3. Gonen
    Gonen
  4. Levine
    Levine
  5. Scher
    Scher
  6. Fong
    Fong
  7. Motzer
    Motzer
  8. Ladanyi
    Ladanyi
  9. Travis
    Travis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)
  7. Department of Pathology and Laboratory Medicine (556)
  8. Center for Hematologic Malignancies (550)
  9. Hematologic Malignancies, Division of (465)
  10. Epidemiology and Biostatistics (464)
  1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bowel obstruction
    Book Section

    Ripamonti, C. I.; Gerdes, H.; Easson, A. M.
    In Berger, A. M.; Shuster, J. L. Jr; Von Roenn, J. H. (Eds.) Principles and Practice of Palliative Care and Supportive Oncology. 4th ed (2013)

    Fulltext@MSK | Save
  • Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab
    Meeting Abstract

    Yuan, J.; Zhou, J.; Dong, Z.; Tandon, S.; Kuk, D.; Panageas, K. S.; Wong, P.; Wolchok, J. D.; Hodi, F. S.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Cross talks between the immune and lymphatic endothelial cells regulate inflammatory lymph node lymphangiogenesis: Defining a new therapeutic approach
    Meeting Abstract

    Elhadad, S.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
    Meeting Abstract

    Budhu, S.; Schaer, D.; Li, Y.; Houghton, A.; Silverstein, S.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • A phase 2 randomized, double-blind, placebocontrolled study of tremelimumab for second and third line treatment in patients with unresectable pleural or peritoneal mesothelioma
    Meeting Abstract

    Krug, L.; di Pietro, A.; Narwal, R.; Robbins, P.; Fu, D.; Shalabi, A.; Ibrahim, R.; Calabro, L.; Kindler, H.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
    Meeting Abstract

    Zamarin, D.; Holmgaard, R.; Subudhi, S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Medical physics in the era of genomic medicine
    Meeting Abstract

    Hricak, H.; Jaffray, D.; Hazle, J.
    Medical Physics (2013)

    Fulltext@MSK | Save
  • Application of new genomic technologies to breast cancer risk assessment
    Book Section

    Robson, M.
    In Benson, J. R.; Gui, G.; Tuttle, T. M. (Eds.) Early Breast Cancer: From Screening to Multidisciplinary Management. 3rd ed (2013)

    Fulltext@MSK | Save